Physician

Ameer Hazma Khan

According to 2025 Medicare claims, Ameer Khan (NPI: 1902118458) practices critical care (intensivists), with the plurality of this provider's patient population coming from Pasquotank, NC. This provider's primary affiliated billing organization is ALBEMARLE PHYSICIAN SERVICES - SENTARA, INC (NPI: 1942443130; TIN: 264592192) and primary practice location at 27909-4994. Khan is affiliated with the Bayview Physicians Group (ACO ID: A2308) and Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 527 traditional Medicare patients, billed 1,529 HCPCS/CPT codes, and received $121,142 in Medicare payments. 2024 Part D data shows 102 prescription claims across 34 beneficiaries totaling $71,653 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). 2024 DME data shows 400 claims. Open Payments data shows 1 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $52,543 and ending at $121,142. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $498 to $71,653. For DME billing, reported payments moved sharply higher in recent years, from $651 to $63,016.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	296	843	$52,543
2017	1,043	3,396	$256,330
2018	1,117	3,155	$217,710
2019	789	2,057	$159,837
2020	216	623	$101,447
2021	298	746	$96,972
2022	534	1,603	$152,111
2023	527	1,529	$121,142
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	11	$498
2016	29	54	$13,468
2017	143	631	$223,840
2018	231	1,213	$544,442
2019	230	1,255	$513,388
2020	56	139	$38,386
2021	13	28	$10,772
2022	66	238	$273,280
2023	76	322	$272,446
2024	34	102	$71,653

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	42	365	$25,429
2018	94	494	$28,223
2019	132	979	$63,837
2020	11	246	$17,640
2021	N/R	28	$11,863
2022	17	188	$9,403
2023	50	513	$50,841
2024	34	400	$62,556

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	1,170	$25,172
Albuterol Sulfate Hfa	Albuterol Sulfate	12	437	$439

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	48	$46,252
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	20	169	$11,890
E1392	Portable oxygen concentrator, rental	Y	14	114	$3,929
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	20	$307
E0570	Nebulizer, with compressor	Y	N/R	49	$178

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$14	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ameer Hazma Khan?

Tedicare shows public-source Medicare data for Ameer Hazma Khan (NPI 1902118458), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ameer Hazma Khan have ACO affiliation data?

Ameer Hazma Khan is shown with ACO affiliation data for Bayview Physicians Group (MSSP, ACO ID A2308) and Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220).

What billing organization is linked to Ameer Hazma Khan?

Ameer Hazma Khan is linked to ALBEMARLE PHYSICIAN SERVICES - SENTARA, INC (billing NPI 1942443130) in the available physician profile data.

Does Ameer Hazma Khan have Open Payments data?

Ameer Hazma Khan has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.